NVLS Insider Trading Activity and SEC Form 4 Filings
NVLS insider trading summary
No open-market insider purchases or sales of Nivalis Therapeutics, Inc. (NVLS) have been reported on SEC Form 4 in the past 12 months.
Latest NVLS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 20, 2017 | Bvf Partners L P/Il | 10% Owner | Buy | $14K (6,359 @ $2.25) |
| Jun 20, 2017 | Bvf Inc/Il | 10% Owner | Buy | $22K (9,732 @ $2.25) |
| Jun 20, 2017 | Biotechnology Value Fund L P | Insider | Buy | $22K (9,732 @ $2.25) |
| Jun 20, 2017 | Bvf Partners L P/Il | 10% Owner | Buy | $22K (9,732 @ $2.25) |
| Jun 20, 2017 | Biotechnology Value Trading Fund OS LP | Insider | Buy | $14K (6,359 @ $2.25) |
| Jun 20, 2017 | BVF Partners OS Ltd. | Insider | Buy | $22K (9,732 @ $2.25) |
| Jun 20, 2017 | Biotechnology Value Fund II LP | Insider | Buy | $22K (9,732 @ $2.25) |
| Jun 20, 2017 | Biotechnology Value Fund L P | Insider | Buy | $14K (6,359 @ $2.25) |
| Jun 20, 2017 | Biotechnology Value Trading Fund OS LP | Insider | Buy | $22K (9,732 @ $2.25) |
| Jun 20, 2017 | BVF Partners OS Ltd. | Insider | Buy | $14K (6,359 @ $2.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.